Scala Bio
Founded 2022 · 34 employees on LinkedIn · 3 known investors
Find your way into Scala Bio
99 people in our graph share verified history with the Scala Bio team — schools, employers, funds. One of them is your warm intro.
Stephen Marcusunlockedknows Ravit Netzer · together at The Hebrew University of Jerusalem (overlapped)
×4knows the team · via Weizmann Institute of Science
×7knows the team · via The Hebrew University of Jerusalem
Scala develops computational protein stability design technology that enables bacterial production of complex human enzymes, applied here to redesign human acetylcholinesterase (AChE) for high-yield, active expression in E. coli. The company's approach supports structural biology, enzyme engineering, and therapeutic and biodefense development in the biotechnology sector.
Founders & leadership
Scala Bio was founded in 2022 by Ravit Netzer and Adi Goldenzweig.
RN
Ravit NetzerinCo-founder & CEORavit Netzer holds a Ph.D. in computational protein design from the Weizmann Institute of Science and brings over a decade of experience in protein engineering, including developing antibody design tools and methods for enhancing protein specificity and affinity. She is co-founder and CEO of Scala Bio, which develops computational protein stability design technology for bacterial production of complex enzymes.
AG
Adi GoldenzweiginCo-founder & CTO
SF
Sarel FleishmaninChief Scientist
Investors · 3
Frequently asked questions
- What does Scala Bio do?
- Scala develops computational protein stability design technology that enables bacterial production of complex human enzymes, applied here to redesign human acetylcholinesterase (AChE) for high-yield, active expression in E. coli. The company's approach supports structural biology, enzyme engineering, and therapeutic and biodefense development in the biotechnology sector.
- Who founded Scala Bio?
- Scala Bio was founded by Ravit Netzer, Adi Goldenzweig in 2022.
- Who are Scala Bio's investors?
- Scala Bio's investors include IT-Farm Corporation, TLV Partners, Deep Insight.